Agenda - Thursday, January 16, 2020

7:30 - 8:00AM Registration & Check-in
8:00 - 8:45AM Keynote Address

Douglas Mann, MD, PhD

"Myocardial Remission: End of the Beginning or Beginning of the End?"

8:45 - 10:30AM

UCAR and Collaborators: (A) Clinical Innovation

Chairs: James Fang, U of Utah and Kirk Knowlton, Intermountain Healthcare

UTAH-INOVA Reverse Remodeling Stages. Palak Shah, MD, Inova

Non-invasive Pressure Volume Loops to Monitor and Diagnose Cardiac Recovery. Christopher Hayward, MD, Sydney, Australia

What happens long-term after we wean a cardiac assist device in heart failure patients? Snehal Patel, MD, Montefiore/Albert Einstein 

How to Start a Cardiac Recovery Clinical and Research Program: the Example of Allegheny, Manreet Kanwar, MD, Allegheny

10:30-11:00 AM Break
11:00AM - 12:30PM

UCAR and Collaborators: (B) Translational Innovation

Chairs: Robin Shaw, MD, PhD Cedars Sinai/U of Utah and Joseph Yost, PhD, U of Utah

Long non-coding RNAs and myocardial recovery mechanisms. Saumya Das, MD, MGH/Harvard

Innate immunity, macrophage heterogeneity and myocardial recovery. Kory Lavine, MD, PhD, Wash U

Regeneration in the human heart. Olaf Bergman, PhD, Karolinska, Sweden

12:30 - 1:30PM

Lunch - Moderated Posters Session

Committee Members: Rami Alharethi, MD, Mark Ibrahim, MD, Virginia Hebl, MD, and Eric Tuday, MD, PhD

1:30 - 2:45PM

Innovation in Myocardial Recovery: Bench to Bedside

Chairs: Jared Rutter, PhD, HHMI/U of Utah and Scott Summers, PhD, U of Utah

Mitochondria and myocardial recovery: lessons from disease models. Dipayan Chaudhuri, MD/PhD U of Utah

The role of metabolism in cardiac repair. Filio Billia, MD/PhD, U of Toronto

Role of the acute sterile immune response in cardiac rejuvenation by cell therapy. Jeff Molkentin, PhD, HHMI/U of Cincinnati

2:45 - 3:00PM Break
3:00 - 4:45PM

Innovation in Myocardial Recovery and MCS

Chairs: Boudi Kfoury, MD, Intermountain Healthcare and Antonio Cabrera, MD, Primary Children’s/U of Utah

Do we effectively unload the heart during chronic mechanical circulatory support? Should we? Nir Uriel, MD, Columbia

Exercise physiology during mechanical circulatory support: implications for myocardial recovery. Finn Gustafsson, MD, U of Copenhagen, Copenhagen, Denmark

What is a sufficient degree of cardiac improvement during LVAD to lead to favorable long-term outcomes after device weaning? Evgenij Potapov, MD, Berlin Heart Center, Germany

What are we learning from pediatric cardiac recovery programs? Melanie Everitt, MD, U of Colorado

4:45 - 6:00PM

“How To” – Focused Practical Discussions

  1. i) How to treat patients during LVAD support, ii) How to serially screen for cardiac recovery iii) Weaning criteria – INTERACTIVE CASES

DISCUSSION LEADERS: Melana Yuzefpolskaya, MD, Columbia, Iki Adachi, MD, Texas Children’s/Baylor, and Omar Wever Pinzon, MD, U of Utah 

(25min)

  1. Myocardial Recovery: Ventricular Assist Device Explantation versus Decommissioning – INTERACTIVE CASES

DISCUSSION LEADERS: Ivan Netuka, MD, PhD, IKEM, Prague, U of Michigan and Craig Selzman, MD, U of Utah

(25min)

  1. Patient-centered decision making and PRO in patients with “Recovered-EF”: provider and patient perspectives - PATIENTS LIVE PARTICIPATION.

DISCUSSION LEADERS: John Spertus, MD, UMKC and Josef Stehlik, MD, U of Utah

(25min)

6:30 - 10:00PM

U-CARS Symposium Reception
University of Utah Rice Eccles Stadium

 

Previous Conferences

ENDORSED BY:

new-hfsa-logo.jpg

Officially endorsed by the Heart Failure Society of America. The opinions presented in this educational activity do not necessarily reflect the opinions or recommendations of the HFSA.